跳至主要内容
临床试验/NCT00891982
NCT00891982已完成3 期

A Phase 3B, Multicenter, Assessor-Blinded Study of the Tolerability of Clindamycin 1%-Tretinoin 0.025% Gel Used in Conjunction With Benzoyl Peroxide 4% Wash in Subjects With Mild to Moderate Facial Acne Vulgaris

Stiefel, a GSK Company5 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
5
主要终点
Local Tolerability - Skin Dryness

研究概览

简要总结

The purpose of this study is to evaluate the tolerability of a combined regimen of a topical antibiotic and retinoid and a benzoyl peroxide wash.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
12 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with mild to moderate facial acne vulgaris, with no history of known or suspected hypersensitivity or previous allergic reaction to any of the ingredients of the study products (eg, topical antibiotics, retinoids or benzoyl peroxide), capable of understanding and willing to provide signed and dated written voluntary informed consent and able to complete the study and to comply with study instructions.
  • Female subjects of childbearing potential must have a negative urine pregnancy test result at baseline and practice a reliable method of contraception throughout the study.

排除标准

  • Use of topical antibiotics on the face within the past 2 weeks or use of systemic antibiotics within the past 4 weeks.

研究组 & 干预措施

CTGel plus BPO wash

Experimental

Benzoyl peroxide (BPO) Wash in the morning and CTGel in the evening

干预措施: CTGel/ BPO Wash (Drug)

CTGel

Active Comparator

Soap Free Cleanser in the morning and CTGel in the evening

干预措施: Soap Free Cleanser and CTGel (Drug)

结局指标

主要结局

Local Tolerability - Skin Dryness

时间窗: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. - Trace 2. - Mild 3. - Moderate 4. - Marked 5. - Severe

Local Tolerability - Skin Scaling

时间窗: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. - Trace 2. - Mild 3. - Moderate 4. - Marked 5. - Severe

Local Tolerability - Erythema (Redness)

时间窗: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. - Trace 2. - Mild 3. - Moderate 4. - Marked 5. - Severe

次要结局

  • Subject Assessment of Burning/Stinging(Week 4)
  • Subject Assessment of Itching(Week 4)

研究者

发起方
Stiefel, a GSK Company
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验